Form 4: Surmodics Inc. Executive Sells Shares to Cover Tax Obligations

John D. Manders, VP Finance and Corporate Controller at Surmodics Inc., sold 152 shares of common stock to cover tax obligations.

Summary

• John D. Manders, a VP Finance and Corporate Controller at Surmodics Inc., sold 152 shares of the company's common stock on December 4, 2024.
• The sale was executed at a price of $39.91 per share.
• Following the transaction, Manders directly owns 8,155 shares of Surmodics Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine insider transaction filing, which is neither positive nor negative for the company's outlook. It is a neutral event.

Industry Context

This is a routine Form 4 filing related to an insider transaction, which is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical insider trading activity.
• The sale of shares by an executive to cover tax obligations is a common occurrence and does not indicate any unusual activity compared to other companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by an executive.

Key Dates

Keywords

Surmodics Inc, SRDX, insider trading, Form 4, stock sale, executive, John Manders, corporate controller